HealthStream Inc (HSTM)
27.03
+0.02
(+0.07%)
USD |
NASDAQ |
May 03, 16:00
27.08
+0.05
(+0.18%)
After-Hours: 20:00
HealthStream Research and Development Expense (Quarterly): 12.03M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 12.03M |
| December 31, 2023 | 11.93M |
| September 30, 2023 | 10.90M |
| June 30, 2023 | 11.03M |
| March 31, 2023 | 11.68M |
| December 31, 2022 | 11.81M |
| September 30, 2022 | 11.48M |
| June 30, 2022 | 10.58M |
| March 31, 2022 | 10.41M |
| December 31, 2021 | 11.45M |
| September 30, 2021 | 10.34M |
| June 30, 2021 | 10.34M |
| March 31, 2021 | 9.525M |
| December 31, 2020 | 8.814M |
| September 30, 2020 | 8.192M |
| June 30, 2020 | 7.83M |
| March 31, 2020 | 7.468M |
| December 31, 2019 | 7.346M |
| September 30, 2019 | 7.195M |
| June 30, 2019 | 7.64M |
| March 31, 2019 | 6.927M |
| December 31, 2018 | 6.586M |
| September 30, 2018 | 6.60M |
| June 30, 2018 | 6.547M |
| March 31, 2018 | 6.001M |
| Date | Value |
|---|---|
| December 31, 2017 | 6.219M |
| September 30, 2017 | 6.002M |
| June 30, 2017 | 6.151M |
| March 31, 2017 | 5.775M |
| December 31, 2016 | 2.71M |
| September 30, 2016 | 7.261M |
| June 30, 2016 | 7.244M |
| March 31, 2016 | 7.018M |
| December 31, 2015 | 7.56M |
| September 30, 2015 | 6.195M |
| June 30, 2015 | 5.815M |
| March 31, 2015 | 4.646M |
| December 31, 2014 | 4.411M |
| September 30, 2014 | 4.211M |
| June 30, 2014 | 4.294M |
| March 31, 2014 | 3.546M |
| December 31, 2013 | 3.163M |
| September 30, 2013 | 3.21M |
| June 30, 2013 | 2.778M |
| March 31, 2013 | 2.606M |
| December 31, 2012 | 2.282M |
| September 30, 2012 | 2.278M |
| June 30, 2012 | 2.182M |
| March 31, 2012 | 1.869M |
| December 31, 2011 | 1.829M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
7.195M
Minimum
Sep 2019
12.03M
Maximum
Mar 2024
9.900M
Average
10.38M
Median
Research and Development Expense (Quarterly) Benchmarks
| HealthEquity Inc | 55.24M |
| Accolade Inc | 24.19M |
| Trxade Health Inc | 0.3665M |
| Simulations Plus Inc | 1.312M |
| Schrodinger Inc | 50.61M |